AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 173 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,106,000 | -46.3% | 280,000 | -28.2% | 0.02% | -43.3% |
| Q2 2022 | $3,920,000 | -18.8% | 390,000 | 0.0% | 0.03% | -6.2% |
| Q1 2022 | $4,828,000 | -41.4% | 390,000 | +8.3% | 0.03% | -38.5% |
| Q4 2021 | $8,233,000 | +18.1% | 360,000 | +14.3% | 0.05% | +13.0% |
| Q3 2021 | $6,971,000 | +85.5% | 315,000 | +8.6% | 0.05% | +91.7% |
| Q2 2021 | $3,758,000 | +23.2% | 290,000 | +23.4% | 0.02% | +20.0% |
| Q1 2021 | $3,051,000 | – | 235,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Berry Street Capital Management LLP | 1,987,500 | $24,605,000 | 2.79% |
| NEA Management Company, LLC | 3,969,834 | $49,146,000 | 1.42% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 133,117 | $1,648,000 | 0.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 435,000 | $3,955,000 | 0.89% |
| ACT CAPITAL MANAGEMENT, LLC | 67,500 | $836,000 | 0.88% |
| Artal Group S.A. | 1,000,000 | $12,380,000 | 0.52% |
| CTC Capital Management, LLC | 12,800 | $158,000 | 0.42% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 581,910 | $7,204,000 | 0.36% |
| Affinity Asset Advisors, LLC | 175,000 | $2,167,000 | 0.35% |
| Bellevue Group AG | 2,405,825 | $29,784,000 | 0.35% |